{"id":"https://openalex.org/W2125149809","doi":"https://doi.org/10.1128/aac.50.2.414-421.2006","title":"Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis","display_name":"Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-25","ids":{"openalex":"https://openalex.org/W2125149809","doi":"https://doi.org/10.1128/aac.50.2.414-421.2006","mag":"2125149809","pmid":"https://pubmed.ncbi.nlm.nih.gov/16436691","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1366877"},"language":"en","primary_location":{"id":"doi:10.1128/aac.50.2.414-421.2006","doi":"https://doi.org/10.1128/aac.50.2.414-421.2006","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.50.2.414-421.2006","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2125149809"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC1366877","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103390461","display_name":"Fred Widmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fred Widmer","raw_affiliation_strings":["Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111954074","display_name":"Lesley C. Wright","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lesley C. Wright","raw_affiliation_strings":["Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010122512","display_name":"Daniel Obando","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel Obando","raw_affiliation_strings":["Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059232728","display_name":"Rosemary Handke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801308011","display_name":"Women's and Children's Hospital","ror":"https://ror.org/03kwrfk72","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801308011"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rosemary Handke","raw_affiliation_strings":["Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia","institution_ids":["https://openalex.org/I2801308011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005734558","display_name":"Ranjini Ganendren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ranjini Ganendren","raw_affiliation_strings":["Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102026483","display_name":"David H. Ellis","orcid":"https://orcid.org/0000-0002-4427-1430","observed_orcids":["https://orcid.org/0000-0002-4427-1430"]},"institutions":[{"id":"https://openalex.org/I2801308011","display_name":"Women's and Children's Hospital","ror":"https://ror.org/03kwrfk72","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801308011"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David H. Ellis","raw_affiliation_strings":["Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia","institution_ids":["https://openalex.org/I2801308011"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022370216","display_name":"Tania Christine Sorrell","orcid":"https://orcid.org/0000-0001-9460-0960","observed_orcids":["https://orcid.org/0000-0001-9460-0960"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tania C. Sorrell","raw_affiliation_strings":["Centre for Clinical Research Excellence in Infections & Bioethics in Haematological Malignancies, University of Sydney, Sydney, NSW 2006","Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Research Excellence in Infections & Bioethics in Haematological Malignancies, University of Sydney, Sydney, NSW 2006","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, ICPMR Building, Westmead Hospital, Westmead, NSW 2145","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5022370216"],"corresponding_institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705"],"apc_list":null,"apc_paid":null,"fwci":3.0349,"has_fulltext":false,"cited_by_count":156,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90567554,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"50","issue":"2","first_page":"414","last_page":"421"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.75,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.75,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.2468000054359436,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11900","display_name":"Fungal Plant Pathogen Control","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/miltefosine","display_name":"miltefosine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antifungal-activity","display_name":"antifungal activity","score":0.847000002861023},{"id":"https://openalex.org/keywords/cryptococcosis","display_name":"cryptococcosis","score":0.8230000138282776},{"id":"https://openalex.org/keywords/cryptococcus-neoformans","display_name":"Cryptococcus neoformans","score":0.9959999918937683},{"id":"https://openalex.org/keywords/lysophospholipase","display_name":"lysophospholipase","score":0.8569999933242798},{"id":"https://openalex.org/keywords/fungal-virulence-factors","display_name":"fungal virulence factors","score":0.6359999775886536},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5320000052452087},{"id":"https://openalex.org/keywords/fungicidal-activity","display_name":"fungicidal activity","score":0.7250000238418579},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.7170000076293945},{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.5590000152587891},{"id":"https://openalex.org/keywords/aspergillus","display_name":"Aspergillus","score":0.9449999928474426},{"id":"https://openalex.org/keywords/scedosporium","display_name":"Scedosporium","score":0.9139999747276306},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C2781417161","wikidata":"https://www.wikidata.org/wiki/Q411787","display_name":"Miltefosine","level":4,"score":0.9591127634048462},{"id":"https://openalex.org/C2779413141","wikidata":"https://www.wikidata.org/wiki/Q1470140","display_name":"Cryptococcosis","level":2,"score":0.8100010752677917},{"id":"https://openalex.org/C3020442560","wikidata":"https://www.wikidata.org/wiki/Q4971815","display_name":"Broad spectrum","level":2,"score":0.7704876661300659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49521389603614807},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.4000895023345947},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3893340826034546},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.35243725776672363},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24101927876472473},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11523979902267456},{"id":"https://openalex.org/C2776555147","wikidata":"https://www.wikidata.org/wiki/Q331283","display_name":"Leishmaniasis","level":2,"score":0.05675444006919861},{"id":"https://openalex.org/C2778689377","wikidata":"https://www.wikidata.org/wiki/Q2046113","display_name":"Visceral leishmaniasis","level":3,"score":0.0},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000217","descriptor_name":"Acyltransferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000217","descriptor_name":"Acyltransferases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003453","descriptor_name":"Cryptococcosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005658","descriptor_name":"Fungi","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006461","descriptor_name":"Hemolysis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008245","descriptor_name":"Lysophospholipase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008245","descriptor_name":"Lysophospholipase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009097","descriptor_name":"Multienzyme Complexes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D009097","descriptor_name":"Multienzyme Complexes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010767","descriptor_name":"Phosphorylcholine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010767","descriptor_name":"Phosphorylcholine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010767","descriptor_name":"Phosphorylcholine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1128/aac.50.2.414-421.2006","doi":"https://doi.org/10.1128/aac.50.2.414-421.2006","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.50.2.414-421.2006","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:324349","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1366877","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1366877","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1366877/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:16436691","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16436691","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/23985","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2440/23985","pdf_url":null,"source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aac.asm.org/content/50/2/414.full","raw_type":"Journal article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:324349","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1366877","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2040134530","display_name":"An enzyme from a pathogenic fungus which may be used as a target for anti-fungal drug development","funder_award_id":"211040","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320310748","display_name":"Westmead Millennium Institute for Medical Research","ror":"https://ror.org/04zj3ra44"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W224334123","https://openalex.org/W243453085","https://openalex.org/W1497721494","https://openalex.org/W1561474071","https://openalex.org/W1581962345","https://openalex.org/W1967441075","https://openalex.org/W1979239192","https://openalex.org/W1980376409","https://openalex.org/W1984961720","https://openalex.org/W2000516223","https://openalex.org/W2003057048","https://openalex.org/W2004247994","https://openalex.org/W2010832347","https://openalex.org/W2014245712","https://openalex.org/W2016587111","https://openalex.org/W2052645253","https://openalex.org/W2059140883","https://openalex.org/W2067683426","https://openalex.org/W2068090419","https://openalex.org/W2070220192","https://openalex.org/W2073906283","https://openalex.org/W2096774695","https://openalex.org/W2105523385","https://openalex.org/W2109483555","https://openalex.org/W2115398724","https://openalex.org/W2118209160","https://openalex.org/W2119880324","https://openalex.org/W2143703444","https://openalex.org/W2149860234","https://openalex.org/W2149921692","https://openalex.org/W2152311269","https://openalex.org/W2158111073","https://openalex.org/W2164443597","https://openalex.org/W2166168462","https://openalex.org/W2170477120","https://openalex.org/W2338253584","https://openalex.org/W2414631081","https://openalex.org/W3080953535","https://openalex.org/W4298113017"],"related_works":["https://openalex.org/W2159246552","https://openalex.org/W2329712894","https://openalex.org/W2184308583","https://openalex.org/W2059140883","https://openalex.org/W2980769487","https://openalex.org/W2248065639","https://openalex.org/W1988737492","https://openalex.org/W305252962","https://openalex.org/W2102919060","https://openalex.org/W2354951113"],"abstract_inverted_index":{"The":[0,104,139,250],"alkyl":[1],"phosphocholine":[2],"drug":[3,23],"miltefosine":[4,30,142,233],"is":[5,20,239,273],"structurally":[6],"similar":[7],"to":[8,136,151,175,203,208,266],"natural":[9],"substrates":[10],"of":[11,29,40,58,73,109,141,186,188,219,247,278],"the":[12,27,41,70,217,226,262,275,279],"fungal":[13,33],"virulence":[14],"determinant":[15],"phospholipase":[16,84],"B1":[17],"(PLB1),":[18],"which":[19,107],"a":[21,55,244],"potential":[22],"target.":[24],"We":[25,230],"determined":[26],"MICs":[28,105,140],"against":[31,81,114,143,155,167],"key":[32],"pathogens,":[34],"correlated":[35],"antifungal":[36,236,280],"activity":[37,66,237],"with":[38,184,213],"inhibition":[39,272],"PLB1":[42,256,271],"activities":[43,95,258],"(PLB,":[44],"lysophospholipase":[45],"[LPL],":[46],"and":[47,50,78,93,101,131,158,165,221,223,238],"lysophospholipase-transacylase":[48],"[LPTA]),":[49],"investigated":[51],"its":[52],"efficacy":[53],"in":[54,241,243],"mouse":[56,245],"model":[57,246],"disseminated":[59,248],"cryptococcosis.":[60,249],"Miltefosine":[61,178,200],"inhibited":[62,97,112],"secreted":[63],"cryptococcal":[64,228],"LPTA":[65,94],"by":[67,98,264],"35%":[68],"at":[69,106,195,259],"subhemolytic":[71],"concentration":[72],"25":[74],"microM":[75,197],"(10.2":[76],"microg/ml)":[77],"was":[79,179],"inactive":[80],"mammalian":[82],"pancreatic":[83],"A2":[85],"(PLA2).":[86],"At":[87],"250":[88],"microM,":[89],"cytosolic":[90],"PLB,":[91],"LPL,":[92],"were":[96,111,134,149,161,173],"25%,":[99],"51%,":[100],"77%,":[102],"respectively.":[103],"90%":[108],"isolates":[110],"(MIC90s)":[113],"Candida":[115,117,119,144,159],"albicans,":[116],"glabrata,":[118],"krusei,":[120],"Cryptococcus":[121,123],"neoformans,":[122,183],"gattii,":[124],"Aspergillus":[125,156,168],"fumigatus,":[126],"Fusarium":[127],"solani,":[128],"Scedosporium":[129,132],"prolificans,":[130],"apiospermum":[133],"2":[135,150,174,189,265],"4":[137,152,193],"microg/ml.":[138,177],"tropicalis":[145],"(n":[146,170],"=":[147,171],"8)":[148,172],"microg/ml,":[153],"those":[154,166],"terreus":[157],"parapsilosis":[160],"8":[162],"microg/ml":[163],"(MIC90),":[164],"flavus":[169],"16":[176],"fungicidal":[180],"for":[181],"C.":[182,214],"rates":[185],"killing":[187],"log":[190],"units":[191],"within":[192],"h":[194],"7.0":[196],"(2.8":[198],"microg/ml).":[199],"given":[201],"orally":[202],"mice":[204],"on":[205,255],"days":[206],"1":[207],"5":[209],"after":[210],"intravenous":[211],"infection":[212],"neoformans":[215],"delayed":[216],"development":[218],"illness":[220],"mortality":[222],"significantly":[224],"reduced":[225],"brain":[227],"burden.":[229],"conclude":[231],"that":[232,270],"has":[234],"broad-spectrum":[235],"active":[240],"vivo":[242],"relatively":[251],"small":[252],"inhibitory":[253],"effect":[254],"enzyme":[257],"concentrations":[260],"exceeding":[261],"MIC":[263],"20":[267],"times":[268],"suggests":[269],"not":[274],"only":[276],"mechanism":[277],"effect.":[281]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2125149809","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
